Argentarii’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$529K Buy
3,548
+9
+0.3% +$1.26K 0.16% 109
2026
Q2
$480K Buy
3,539
+152
+4% +$20K 0.14% 125
2026
Q1
$472K Buy
3,387
+35
+1% +$4.9K 0.17% 118
2025
Q4
$411K Buy
3,352
+7
+0.2% +$851 0.13% 126
2025
Q3
$371K Buy
3,345
+3
+0.1% +$341 0.15% 110
2025
Q2
$371K Sell
3,342
-50
-1% -$5.32K 0.17% 105
2025
Q1
$380K Buy
3,392
+99
+3% +$10.2K 0.19% 111
2024
Q4
$304K Buy
+3,293
New +$296K 0.15% 113

Other funds holding GILD

Argentarii's GILD Position: Q3 2026 in Review

Argentarii increased its Gilead Sciences (GILD) stake by 0.25% in Q3 2026, buying an estimated $1.26K and bringing the position to 3,548 shares worth $529K. The position accounts for 0.16% of the portfolio, ranked #109.

Argentarii first reported a position in GILD in Q4 2024 and has held it in 8 quarters since. 2,335 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Argentarii held 3,548 shares of Gilead Sciences worth $529K as of Q3 2026.
  • Argentarii bought 9 Gilead Sciences shares in Q3 2026, an estimated $1.26K.
  • Gilead Sciences made up 0.16% of Argentarii's portfolio in Q3 2026, its #109 holding.
  • Argentarii first reported a position in Gilead Sciences in Q4 2024 and has held it in 8 quarters since.
  • 2,335 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Argentarii's 13F filing for Q3 2026, filed 28 Oct 2026.